Sen. Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices

  • Oops!
    Something went wrong.
    Please try again later.

Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, Ozempic and Wegovy.